21 CFR 526.365
§ 526.365 Cephapirin sodium.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 526.365, § 526.365 Cephapirin sodium, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87664
- Permanent ID
ys:prov:87664@1- SHA-256
92c0c83dbbde3b0e4dfffd88a3bce463d93c407cebe98e58d61d1ad08ef04458
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each single-dose, 10-milliliter syringe contains 200 milligrams (mg) cephapirin sodium activity.
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.115 of this chapter.
(d) Conditions of use in lactating cows—(1) Amount. Infuse the contents of one syringe (200 mg cephapirin activity) into each infected quarter immediately after the quarter has been completely milked out. Do not milk out for 12 hours. Repeat once only in 12 hours.
(2) Indications for use. For the treatment of mastitis in lactating cows caused by susceptible strains of Streptococcus agalactiae and Staphylococcus aureus including strains resistant to penicillin.
(3) Limitations. Milk that has been taken from animals during treatment and for 96 hours after the last treatment must not be used for food. Treated animals must not be slaughtered for food until 4 days after the last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.